Oisin Biotechnologies
Organization Description
Oisin Biotechnologies are developing a plasmid-based approach to destroying senescent and cancer cells. This approach may allow for higher selectivity when compared to drug approaches and could reduce side effects too.
Team
Gary Hudson
Oisin Biotechnologies - Executive Chairman
Stephen Hilbert
Oisin Biotechnologies - CBO
Related Topics
Why we Age: Cellular Senescence
As your body ages, more of your cells become senescent. Senescent cells do not divide or support the tissues of which they are part; instead, they emit potentially harmful chemical signals, collectively known as the senescence-associated secretory phenotype (SASP), which encourages nearby cells to enter the same senescent state. Their presence causes many problems: they degrade tissue function, increase chronic inflammation, and can even eventually raise the risk of cancer and other age-related ...
Read More
Read More